Close

RPRX Financial Facts

Product royalties: 0
Research and development: 3.23M
See Full Income Statement

Total current assets: 7.26M
Other assets, net: 1.34M
See Full Balance Sheet

Repros Therapeutics Inc. (RPRX) Earnings

  |   Expand Research on RPRX
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +6.3% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +1.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/10/22 Q222 N/A$0.80 N/A N/A$558.81M N/A N/A N/A
8/11/21 Q221 $0.00N/A N/A $555M$511M N/A Details
3/31/17 Q416 -$0.16N/A N/A N/AN/A N/A Details
11/8/16 Q316 -$0.17-$0.18 +$0.01$10K$1K N/A Details
8/9/16 Q216 -$0.18N/A N/A N/AN/A N/A Details
5/10/16 Q116 -$0.20-$0.22 +$0.02N/AN/A N/A Details
3/14/16 Q415 -$0.26-$0.27 +$0.01N/AN/A N/A Details
11/9/15 Q315 -$0.27-$0.29 +$0.02N/AN/A N/A Details